Intracellular Assembly of Kell and XK Blood Group Proteins

Total Page:16

File Type:pdf, Size:1020Kb

Intracellular Assembly of Kell and XK Blood Group Proteins View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1461 (1999) 10^18 www.elsevier.com/locate/bba Intracellular assembly of Kell and XK blood group proteins David Russo, Soohee Lee, Colvin Redman * Lindsley F. Kimball Research Institute, The New York Blood Center, 310 East 67 Street, New York, NY 10021, USA Received 22 June 1999; accepted 13 August 1999 Abstract Kell, a 93 kDa type II membrane glycoprotein, and XK, a 444 amino acid multi-pass membrane protein, are blood group proteins that exist as a disulfide-bonded complex on human red cells. The mechanism of Kell/XK assembly was studied in transfected COS cells co-expressing Kell and XK proteins. Time course studies combined with endonuclease-H treatment and cell fractionation showed that Kell and XK are assembled in the endoplasmic reticulum. At later times the Kell component of the complex was not cleaved by endonuclease-H, indicating N-linked oligosaccharide processing and transport of the complex to a Golgi and/or a post-Golgi cell fraction. Surface-labeling of transfected COS cells, expressing both Kell and XK, demonstrated that the Kell/XK complex travels to the plasma membrane. XK expressed in the absence of Kell was also transported to the cell surface indicating that linkage of Kell and XK is not obligatory for cell surface expression. ß 1999 Elsevier Science B.V. All rights reserved. Keywords: Kell; XK; Blood group; Red cell; Protein assembly 1. Introduction and the Kell blood group system is important in transfusion medicine since Kell antibodies can elicit Kell is a 93 kDa type II membrane glycoprotein [1] severe reactions if incompatible blood is transfused and XK a 444 amino acid integral membrane protein [5,6]. Kell antibodies can also suppress erythropoiesis that is predicted to span the membrane 10 times [2]. and cause anemic disease in newborn infants [7^9]. Both Kell and XK proteins display blood group anti- The di¡erent Kell antigens are due to point muta- gens and on human red cell membranes Kell and XK tions in KEL leading to single amino acid changes in are linked by a disul¢de bond [3,4]. Kell is highly the extracellular domain of the glycoprotein [10^15]. polymorphic, and over 20 di¡erent antigens are rec- XK on the other hand, carries a single blood group ognized as part of the Kell blood group system. antigen, termed Kx, which is present in all red cells Some of the Kell antigens are strong immunogens except in the rare McLeod phenotype. McLeod red cells have aberrant shape, appearing as acanthocytes, and together with lack of XK there is a marked Abbreviations: NEP, neutral endopeptidase; ECE, endothelin diminution of Kell protein and all Kell antigens are converting enzyme; ER, endoplasmic reticulum; SDS, sodium markedly weakened. Lack of XK is associated with dodecyl sulfate; PAGE, polyacrylamide gel electrophoresis; disease and most McLeods exhibit a late onset form PMSF, phenylmethyl sulfonyl £uoride; TPCK, N-tosyl-L-phenyl- alanine chloromethyl ketone of muscular dystrophy, cardiomyopathy, and nerve * Corresponding author. Fax: +1-212-879-0243; degeneration [5,6,16,17]. E-mail: [email protected] Expression of wild-type and mutant recombinant 0005-2736 / 99 / $ ^ see front matter ß 1999 Elsevier Science B.V. All rights reserved. PII: S0005-2736(99)00148-0 BBAMEM 77694 25-10-99 D. Russo et al. / Biochimica et Biophysica Acta 1461 (1999) 10^18 11 Kell and XK proteins has indicated that Kell Cys72, peptide representing the N-terminal domain of Kell which is close to the membrane spanning domain, is protein (amino acids 2 to 31) was synthesized by the linked to XK Cys347 located in a small `loop' which Microchemistry Laboratory of the New York Blood contributes the ¢fth extracellular XK domain [18]. Center. Polyclonal antibodies were produced in rab- Although Kell and XK exist on red cell membranes bits by injection of the synthetic peptides mixed with as a disul¢de-bonded complex, association of the two Freunds adjuvant and the antisera were a¤nity pu- proteins is not needed for presentation of Kell blood ri¢ed. group antigens. Expression of Kell protein in a vari- ety of transfected cells indicates that Kell can be 2.2. Construction of expression vectors transported to the plasma membrane without co-ex- pression of XK and the recombinant protein ex- XK cDNA was a generous gift from Drs. M. Ho presses Kell surface antigens [15,19]. Likewise, Kx and A.P. Monaco, Imperial Cancer Research Fund antigen is present in Ko (null) red cell membranes Laboratories, Institute of Molecular Medicine, John which have little, or no, Kell protein [5,6]. It is not Radcli¡e Hospital, Oxford, England. Two pRC/ known, however, whether the association of Kell and CMV expression vectors were constructed. One vec- XK is needed for red cell functions, since the com- tor contained only XK cDNA and the other had plete physiological roles of the two proteins remain both XK and Kell cDNAs. For the vector containing to be determined. Kell protein has close structural only XK, the cDNA was placed in pRc/CMV (Invi- and sequence homology to the M13 or neprilysin trogen, Inc.) in HindIII and XbaI cloning sites. For sub-family of zinc endopeptidases [15] which include the vector containing both XK and Kell, the Kell neutral endopeptidase 24.1 (NEP), endothelin con- cDNA was modi¢ed to contain a Kozak sequence verting enzyme (ECE) and the product of the PEX (GCCGCCACC) [26] before the ATG initiation co- gene [20^24]. The members of the M13 family of don. The modi¢ed Kell cDNA and XK cDNA were membrane zinc endopeptidases are involved in the placed in tandem, each with its own CMV promoter activation and inactivation of biologically active pep- and adenylation signal, into pRc/CMV as previously tide hormones. Recently we determined that the ex- described. tracellular domain of Kell protein, like ECE-1, acti- vates the endothelins, but that unlike ECE-1 Kell 2.3. Transient transfection of COS cells preferentially activates endothelin-3 rather than en- dothelin-1 [25]. Although absence of XK is associ- COS-1 cells (ATCC CRL 1650) were transfected ated with red cell acanthocytosis and with muscle by electroporation using a Gibco Cell Porator with and nerve disorders and its primary structure has an electrical pulse of 250 V and 330 WF. About features that suggest that it may be a membrane 2U107 cells were suspended for 15 min in 1 ml of transporter [2], its function remains to be deter- Dulbecco's phosphate-bu¡ered saline with 10 Wgof mined. plasmid DNA prior to electroporation. The cells To study the mechanism of Kell/XK assembly we were allowed to recover in ice for 10 min and were have, using co-expression of Kell and XK in COS seeded at about 5U106 cells on 100 mm plastic Petri cells, determined the biosynthesis, site of assembly dishes (Falcon, Becton Dickinson, Franklin Lakes, and intracellular transport of Kell and XK proteins. NJ, USA). The cells were cultured in 10 ml of RPMI 1640 medium supplemented with 10% fetal bovine serum and grown to con£uence, usually in 2. Materials and methods 2 days. 2.1. Antibodies 2.4. Metabolic labeling of transfected COS cells with 35 L-[ S]methionine A 42-mer synthetic peptide, corresponding to the predicted second extracellular loop of XK was pre- Con£uent COS-1 cells were washed with phos- pared by Synpep, Deblin, CA, USA and a 30-mer phate-bu¡ered saline and incubated at 37³C for 30 BBAMEM 77694 25-10-99 12 D. Russo et al. / Biochimica et Biophysica Acta 1461 (1999) 10^18 min in 1 ml of L-methionine-free Dulbecco's minimal from the cytoplasmic domain of Kell, were added essential medium (Life Technologies, Inc.) containing and incubated overnight at 4³C. The immune com- 35 0.5 mCi of L-[ S]methionine (NEN Research Prod- plex was isolated with protein A-Sepharose, the pro- ucts, Boston, MA, USA, speci¢c activity 1110 Ci/ teins eluted with SDS bu¡er (0.125 M Tris-HCl, pH mmol). The cells were then washed twice with phos- 6.8, 1% SDS, 5% glycerol) containing 4 M urea and phate-bu¡ered saline and incubated with growth me- separated on 9% polyacrylamide gels [18,30] or pre- dium for various periods of time. casted 4^12% Tris-glycine gradient gels (Novex, San- diego, CA, USA). 2.5. Cell fractionation The immune complex was treated with endonu- clease-H (New England BioLabs Inc., Beverley, About 108 transfected COS cells were lysed with MA, USA) to remove the high mannose chitobiose 2 ml of ice-cold water for 5 min and the cells further core from glycoproteins [31] as recommended by the disrupted with a loose-¢tting Dounce homogenizer. manufacturer. The control samples that were not The cell suspension was adjusted to 0.25 M sucrose treated with endonuclease-H underwent the same and centrifuged at 500Ug for 10 min to remove un- procedure except that the enzyme was not added. broken cells, debris and a nuclear fraction. The supernatant fraction was adjusted to 1.38 M sucrose 2.8. Two-dimensional gel electrophoresis and overlaid over 2 M sucrose. A discontinuous su- crose gradient of 1.1 M, 0.6 M and 0.25 M sucrose In the ¢rst dimension, radioactive proteins present was then applied and centrifuged in a Beckman SW in the immunoprecipitate obtained with antibody to 40.1 rotor at 105 000Ug for at least 3 h.
Recommended publications
  • Jka, Jkb, Jk – Co-Dominant Inheritance – Jk Is a Silent Allele
    Kidd Blood Group System Qun Lu, MD Assistant Professor Division of Transfusion Medicine Department of Pathology and Laboratory Medicine UCLA, School of Medicine Los Angeles, California 02-05-2009 History of Kidd Blood Group System . Jka was discovered in 1951 by Allen: Mrs. Kidd had hemolytic disease of newborn (HDN) in her son. A new RBC alloantibody was detected in her serum, reacted with her husband’s RBCs. Jkb was found in 1953 by Plaut . The antigens were independent of other known blood groups. They named after Mrs. Kidd. Jk null phenotyp was found in 1959 by Pinkerton. Since the specificities were inseparable, the antibody was renamed anti-Jk3 which recognizes an antigen found whenever Jka or Jkb is present. ISBT Human Blood Group Systems ISBT Number Name Abbreviation 001 ABO ABO 002 MNS MNS 003 P P 004 Rh RH 005 Lutheran LU 006 Kell KEL 007 Lewis LE 008 Duffy FY 009 Kidd JK 010 Diego DI 011 Cartwright YT 012 XG XG 013 Scianna SC 014 Dombrock DO 015 Colton CO 016 Landsteiner-Wiener LW 017 Chido/Rodgers CH/RG 018 Hh H 019 Kx XK 020 Gerbich GE 021 Cromer CROM 022 Knops KN 023 Indian IN 024 Ok OK 025 Raph RAPH Kidd Antigens . Genotype: – Genes located on chromosome 18 – Three alleles Jka, Jkb, Jk – Co-dominant Inheritance – Jk is a silent allele . Common antigen ---- JK3 Ag: – Present with Jka and/or Jkb antigens – Whenever you have Jka or Jkb antigens on the RBC you also have Jk3 antigen. – Anti- Jk3 is against Jka,Jkb, Jk3 antigens, transfuse with Jk(a-b-) blood, very difficult to find Homozygous Heterozygous for Jka or Jkb for JKa and Jkb.
    [Show full text]
  • Blood Groups – Kell Group
    Blood Groups – Kell Group Qun Lu, MD Assistant Professor Division of Transfusion Medicine Department of Pathology and Laboratory Medicine UCLA, School of Medicine Los Angeles, California 2008-12-17 1 History . Discovered in 1946: an antibody was identified in Mrs. Kellacher, the antibody reacted with her newborn infant, her older daughter, her husband, and about 9% of the white population. Antigen is named after her, called Kell . In 1949, k antigen was discovered by Levine, called Cellano antigen . Kpa, Kpb antigens were discovered in 1957, 1958 . Jsa, Jsb antigens were discovered in 1957, 1963 . Inheritance patterns and statistics confirmed these antigens are related to the Kell system 2 History . K0 (null phenotype) was discovered in 1957. It helped to figure out the relationship between K, k, Kpa, Kpb, Jsa, Jsb antigens, because anti- K0 reacted with these antigen positive cells . McLeod phenotype was discovered by Allen and coworkers in 1961: weaken expression of Kell antigens 3 Xk Gene KEL gene codes for the entire Kell system KEL Gene glycoprotein, some 720 amino acids. It also codes for the Km antigen. RBC Kell system glycoprotein: Kx Km Kell Ag’s reside here. Kx is NOT a Kell system antigen -but there is interaction between the Kell protein and the Kx antigen. The Xk gene is located on the X chromosome 4 Kell Antigens . Routinely tested Kell antigens: K, k, Kpa, Kpb, Jsa, Jsb . Other Kell antigens: Ku, Ula, Wka, Kx, Km, Kpc,(only exist on Kpa-, Kpb- cells), Cent, Callais… . Ku – an universal Kell antigen present on all cells except K0 cells (K null phenotype)\ .
    [Show full text]
  • Mirepoix LLC on Behalf of Caris Life Sciences, June 22, 2020 No Revisions to These Recommendations
    0211U Oncology (pan-tumor), DNA and RNA by next generation sequencing, utilizing formalin-fixed paraffin-embedded tissue, interpretative report for single nucleotide variants, copy number alterations, tumor mutational burden, and microsatellite instability, with therapy association Submitted by Joel de Jesus, Mirepoix LLC on behalf of Caris Life Sciences, June 22, 2020 No revisions to these recommendations 0211U: MI Cancer Seek™ - NGS analysis C. Public Comment Rationale • Recommendation to crosswalk 0211U MI Cancer Seek is a combined whole transcriptome AND whole exome to 0019U (NLA=$3675.00) + 0036U sequencing test that is equivalent to (NLA=$4780.00) performing both: • 0019U: Oncology, RNA, gene expression • 1x multiplier for each by whole transcriptome sequencing, formalin-fixed paraffin-embedded tissue • Recommendation of an NLA equal to or fresh frozen tissue, predictive $8455 for 0211U algorithm reported as potential targets for therapeutic agents • 0036U: Exome (ie, somatic mutations), paired formalin-fixed paraffin-embedded tumor tissue and normal specimen, sequence analyses Submitted by Joel de Jesus, Mirepoix LLC on behalf of Caris Life Sciences, June 22, 2020 No revisions to these recommendations 0211U: MI Cancer Seek™ - NGS analysis C. 0019U* 0211U 0036U** Assay type Whole Whole Whole Whole Transcriptome Transcriptome Exome Exome Sequencing Sequencing Sequencing Sequencing Platform NGS NGS (Illumina) NGS (Illumina) RNASeq RNASeq & DNASeq DNASeq Samples tested FFPE & frozen tumor tissue FFPE tumor tissue FFPE tumor tissue
    [Show full text]
  • Unmasking of Novel Mutations Within XK Gene That Could Be Used As Diagnostic Markers to Predict Mcleod Syndrome: Using in Silico Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/540153; this version posted February 5, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Unmasking of novel mutations within XK gene that could be used as Diagnostic Markers to Predict McLeod syndrome: Using in silico analysis Mujahed I. Mustafa1,2*and Mohamed A. Hassan2 1-Department of Biochemistry, University of Bahri, Sudan 2-Department of Biotechnology, Africa city of Technology, Sudan *Crossponding author: Mujahed I. Mustafa: email: [email protected] Abstract: Background: McLeod neuroacanthocytosis syndrome is a rare X-linked recessive multisystem disorder affecting the peripheral and central nervous systems, red blood cells, and internal organs. Methods: We carried out in silico analysis of structural effect of each SNP using different bioinformatics tools to predict substitution influence on protein structural and functional level. Result: 2 novel mutations out of 104 nsSNPs that are found to be deleterious effect on the XK structure and function. Conclusion: The present study provided a novel insight into the understanding of McLeod syndrome, SNPs occurring in coding and non-coding regions, may lead to RNA alterations and should be systematically verified. Functional studies can gain from a preliminary multi-step approach, such as the one proposed here; we prioritize SNPs for further genetic mapping studies. This will be a valuable resource for neurologists, hematologists, and clinical geneticists on this rare and debilitating disease.
    [Show full text]
  • Mcleod Neuroacanthocytosis Syndrome
    McLeod neuroacanthocytosis syndrome Description McLeod neuroacanthocytosis syndrome is primarily a neurological disorder that occurs almost exclusively in boys and men. This disorder affects movement in many parts of the body. People with McLeod neuroacanthocytosis syndrome also have abnormal star- shaped red blood cells (acanthocytosis). This condition is one of a group of disorders called neuroacanthocytoses that involve neurological problems and abnormal red blood cells. McLeod neuroacanthocytosis syndrome affects the brain and spinal cord (central nervous system). Affected individuals have involuntary movements, including jerking motions (chorea), particularly of the arms and legs, and muscle tensing (dystonia) in the face and throat, which can cause grimacing and vocal tics (such as grunting and clicking noises). Dystonia of the tongue can lead to swallowing difficulties. Seizures occur in approximately half of all people with McLeod neuroacanthocytosis syndrome. Individuals with this condition may develop difficulty processing, learning, and remembering information (cognitive impairment). They may also develop psychiatric disorders, such as depression, bipolar disorder, psychosis, or obsessive-compulsive disorder. People with McLeod neuroacanthocytosis syndrome also have problems with their muscles, including muscle weakness (myopathy) and muscle degeneration (atrophy). Sometimes, nerves that connect to muscles atrophy (neurogenic atrophy), leading to loss of muscle mass and impaired movement. Individuals with McLeod neuroacanthocytosis
    [Show full text]
  • Conditions Causing Weak Expression of Kell System Antigens
    Review: conditions causing weak expression of Kell system antigens R. ØYEN, G.R. HALVERSON, AND M.E. REID Key Words: Kell system, KEL gene, weakened Kell Kpa Cis-Modifying Phenotype antigens Kell system antigens (other than Kpa) on Kp(a+b–) RBCs may be weaker than on RBCs of common Kell type Background a 1 due to the cis-modifying effect of the Kp allele. This phe- Since the discovery of anti-K in 1946, the Kell blood 9 2 nomenon was first noted decades ago by Allen et al., group system has grown to include 22 antigens. The sys- who found that K+k+Kp(a+b+) RBCs were weakly reac- tem has five sets of alleles that produce antithetical anti- tive with some examples of anti-k. We have seen numer- gens, one or two of low-incidence and the others of ous examples of anti-k that react 2+ with RBCs of high-incidence. In addition, eight antigens of high-inci- common Kell phenotype but are nonreactive (by direct dence and three of low-incidence have been recognized testing) with a K+k+Kp(a+b+) RBC sample that is rou- (Table 1). The system also includes a null phenotype, Ko, tinely included on our in-house panel. Kell system anti- in which the red blood cells (RBCs) are devoid of all Kell gens, including the Kpa antigen, are expressed weakly on system antigens, and a Kellmod phenotype, in which all RBCs from Kpa/Ko individuals.9–11 In fact, the cis-modi- Kell antigens are expressed weakly.
    [Show full text]
  • Autocrine IFN Signaling Inducing Profibrotic Fibroblast Responses By
    Downloaded from http://www.jimmunol.org/ by guest on September 23, 2021 Inducing is online at: average * The Journal of Immunology , 11 of which you can access for free at: 2013; 191:2956-2966; Prepublished online 16 from submission to initial decision 4 weeks from acceptance to publication August 2013; doi: 10.4049/jimmunol.1300376 http://www.jimmunol.org/content/191/6/2956 A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Autocrine IFN Signaling Feng Fang, Kohtaro Ooka, Xiaoyong Sun, Ruchi Shah, Swati Bhattacharyya, Jun Wei and John Varga J Immunol cites 49 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130037 6.DC1 This article http://www.jimmunol.org/content/191/6/2956.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 23, 2021. The Journal of Immunology A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Inducing Autocrine IFN Signaling Feng Fang,* Kohtaro Ooka,* Xiaoyong Sun,† Ruchi Shah,* Swati Bhattacharyya,* Jun Wei,* and John Varga* Activation of TLR3 by exogenous microbial ligands or endogenous injury-associated ligands leads to production of type I IFN.
    [Show full text]
  • Disorders of the Red Cell Membrane
    IRON2009_CAP.16(402-435):EBMT2008 4-12-2009 16:32 Pagina 402 * CHAPTER 16 Disorders of the red cell membrane Jean Delaunay, Jean-Pierre Cartron IRON2009_CAP.16(402-435):EBMT2008 4-12-2009 16:32 Pagina 403 CHAPTER 16 • Disorders of the red cell membrane 1. Introduction The red cell membrane designates, in a strict sense, the plasma membrane of the erythrocyte, the only membrane remaining in the circulating red cell. It consists of a lipid bilayer, a variety of proteins studded therein, and the glycans that stick outward, being linked covalently either to proteins or to lipids. Protein or glycan domains constitute the structural bases of blood groups. In a wider sense, the red cell membrane includes, in addition, an unusually thick, bidimensional protein network that provides the red cell with its mechanical properties of both resistance and flexibility. This protein network is named the red cell skeleton. Most of the genes encoding the membrane proteins are known. Mutations in these genes account for a variety of different conditions, most of which are haemolytic anaemias of various descriptions. 2. The red cell membrane A schematic picture of the red cell membrane is shown in Figure 1. A classical description of the lipid bilayer was provided in a review by Lux and Palek (1). During the last decade, a major breakthrough has been the discovery of lipid rafts in membranes in general, and in the red cell membrane in particular. Rafts are detergent-resistant plasma membrane microdomains. They are rich in sphingolipids. They are also rich in cholesterol. They exist as islets having a phase different to that of the loosely packed disordered state of the rest of the bilayer.
    [Show full text]
  • XK Mutations in Mcleod Syndrome and Interaction Between XK Protein and Chorein
    ARTICLE OPEN ACCESS Novel pathogenic XK mutations in McLeod syndrome and interaction between XK protein and chorein Yuka Urata, MD, Masayuki Nakamura, MD, PhD, Natsuki Sasaki, MD, PhD, Nari Shiokawa, MD, PhD, Correspondence Yoshiaki Nishida, MD, Kaoru Arai, MD, Hanae Hiwatashi, MS, Izumi Yokoyama, BS, Shinsuke Narumi, MD, Dr. Nakamura nakamu36@ Yasuo Terayama, MD, PhD, Takenobu Murakami, MD, PhD, Yoshikazu Ugawa, MD, PhD, Hiroki Sakamoto, MD, m.kufm.kagoshima-u.ac.jp Satoshi Kaneko, MD, PhD, Yusuke Nakazawa, MD, Ryo Yamasaki, MD, PhD, Shoko Sadashima, MD, Toshiaki Sakai, MD, Hiroaki Arai, MD, and Akira Sano, MD, PhD Neurol Genet 2019;5:e328. doi:10.1212/NXG.0000000000000328 Abstract Objective To identify XK pathologic mutations in 6 patients with suspected McLeod syndrome (MLS) and a possible interaction between the chorea-acanthocytosis (ChAc)- and MLS-responsible proteins: chorein and XK protein. Methods Erythrocyte membrane proteins from patients with suspected MLS and patients with ChAc, ChAc mutant carriers, and normal controls were analyzed by XK and chorein immunoblotting. We performed mutation analysis and XK immunoblotting to molecularly diagnose the patients with suspected MLS. Lysates of cultured cells were co-immunoprecipitated with anti-XK and anti-chorein antibodies. Results All suspected MLS cases were molecularly diagnosed with MLS, and novel mutations were identified. The average onset age was 46.8 ± 8 years, which was older than that of the patients with ChAc. The immunoblot analysis revealed remarkably reduced chorein immunoreactivity in all patients with MLS. The immunoprecipitation analysis indicated a direct or indirect chorein-XK interaction. Conclusions In this study, XK pathogenic mutations were identified in all 6 MLS cases, including novel mutations.
    [Show full text]
  • Handouts Program-Handouts.Aspx
    Handouts http://www.immucor.com/en-us/Pages/Educational- Program-Handouts.aspx 2 All Content © Immucor, Inc. 2019 Advanced Track Webinars Link to register: https://immucor.webinato.com/register 3 All Content © Immucor, Inc. 2019 Advanced Track Webinars Link to register: https://immucor.webinato.com/register 4 All Content © Immucor, Inc. 5 All Content © Immucor, Inc. Link to register: https://immucor.webinato.com/register 6 All Content © Immucor, Inc. learn.immucor.com 7 All Content © Immucor, Inc. Continuing Education • PACE, Florida and California DHS • 1.0 Contact Hours • Each attendee must register to receive CE at: https://www.surveymonkey.com/r/TheJollyBloodBanker • Registration deadline is April 5, 2019 • Certificates will be sent via email only to those who have registered April 19, 2019 8 All Content © Immucor, Inc. Questions? • You are all muted • Q&A following session - Type in questions 9 All Content © Immucor, Inc. • Course content is for information and illustration purposes only. Immucor makes no representation or warranties about the accuracy or reliability of the information presented, and this information is not to be used for clinical or maintenance evaluations. • The opinions contained in this presentation are those of the presenter and do not necessarily reflect those of Immucor. 10 All Content © Immucor, Inc. The Jolly Blood Banker and “Other” Blood Groups Jill R. Storry, PhD FIBMS Associate Professor, Lund University Technical Director, Immunohematology Clinical Immunology and Transfusion Medicine, Lund Blood systems
    [Show full text]
  • Hereditary Spherocytosis, Elliptocytosis, and Other Red Cell Membrane Disorders☆
    YBLRE-00309; No of Pages 12 Blood Reviews xxx (2013) xxx–xxx Contents lists available at SciVerse ScienceDirect Blood Reviews journal homepage: www.elsevier.com/locate/blre Review Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders☆ Lydie Da Costa a,b,c,d,⁎, Julie Galimand a,1, Odile Fenneteau a, Narla Mohandas e,2 a AP-HP, Service d'Hématologie Biologique, Hôpital R. Debré, Paris, F-75019, France b Université Paris Diderot, Sorbonne Paris Cité, Paris, F-75010, France c Unité INSERM U773, Faculté de Médecine Bichat-Claude Bernard, Paris, F-75018, France d Laboratoire d'Excellence GR-Ex, France e New York Blood Center, New York, USA article info abstract Available online xxxx Hereditary spherocytosis and elliptocytosis are the two most common inherited red cell membrane disorders resulting from mutations in genes encoding various red cell membrane and skeletal proteins. Red cell membrane, Keywords: a composite structure composed of lipid bilayer linked to spectrin-based membrane skeleton is responsible for Hereditary spherocytosis the unique features of flexibility and mechanical stability of the cell. Defects in various proteins involved in Elliptocytosis linking the lipid bilayer to membrane skeleton result in loss in membrane cohesion leading to surface area loss Pyropoikilocytosis and hereditary spherocytosis while defects in proteins involved in lateral interactions of the spectrin-based skel- Stomatocytosis eton lead to decreased mechanical stability, membrane fragmentation and hereditary elliptocytosis. The disease Red cell membrane Hemolysis severity is primarily dependent on the extent of membrane surface area loss. Both these diseases can be readily diagnosed by various laboratory approaches that include red blood cell cytology, flow cytometry, ektacytometry, electrophoresis of the red cell membrane proteins, and mutational analysis of gene encoding red cell membrane proteins.
    [Show full text]
  • Protein 4.1R-Dependent Multiprotein Complex: New Insights Into the Structural Organization of the Red Blood Cell Membrane
    Protein 4.1R-dependent multiprotein complex: New insights into the structural organization of the red blood cell membrane Marcela Salomao*, Xihui Zhang*, Yang Yang*, Soohee Lee†, John H. Hartwig‡, Joel Anne Chasis§, Narla Mohandas*, and Xiuli An*¶ *Red Cell Physiology Laboratory and †Membrane Biochemistry Laboratory, New York Blood Center, New York, NY 10065; ‡Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; and §Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, Berkeley, CA 94720 Communicated by Joseph F. Hoffman, Yale University School of Medicine, New Haven, CT, April 3, 2008 (received for review January 4, 2008) Protein 4.1R (4.1R) is a multifunctional component of the red cell The membrane-skeletal network is coupled to the lipid bilayer membrane. It forms a ternary complex with actin and spectrin, which through transmembrane proteins. One such linkage is generated by defines the nodal junctions of the membrane-skeletal network, and ankyrin, which forms a bridge between spectrin and band 3 tet- its attachment to the transmembrane protein glycophorin C creates a ramers (14–17). Band 3 also contains a binding site for carbonic bridge between the protein network and the membrane bilayer. We anhydrase II at its C-terminal cytoplasmic domain (18) and binding now show that deletion of 4.1R in mouse red cells leads to a large sites for glycolytic enzymes, hemoglobin, and protein 4.2 at its diminution of actin accompanied by extensive loss of cytoskeletal N-terminal cytoplasmic domain (19). In addition, there is a clear lattice structure, with formation of bare areas of membrane.
    [Show full text]